Mitochondrial complex I deficiency in Parkinson's disease - PubMed (original) (raw)
Mitochondrial complex I deficiency in Parkinson's disease
A H Schapira et al. Lancet. 1989.
No abstract available
Comment in
- Mitochondrial function in Parkinson's disease.
Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD Jr, Turnbull DM. Bindoff LA, et al. Lancet. 1989 Jul 1;2(8653):49. doi: 10.1016/s0140-6736(89)90291-2. Lancet. 1989. PMID: 2567823 No abstract available.
Similar articles
- Mitochondrial encephalomyopathy. Association with an NADH dehydrogenase deficiency.
van Erven PM, Gabreëls FJ, Ruitenbeek W, Renier WO, Fischer JC. van Erven PM, et al. Arch Neurol. 1987 Jul;44(7):775-8. doi: 10.1001/archneur.1987.00520190079019. Arch Neurol. 1987. PMID: 3593065 - Tissue specific defect of complex I of the mitochondrial respiratory chain.
Watmough NJ, Birch-Machin MA, Bindoff LA, Aynsley-Green A, Simpson K, Ragan CI, Sherratt HS, Turnbull DM. Watmough NJ, et al. Biochem Biophys Res Commun. 1989 Apr 28;160(2):623-7. doi: 10.1016/0006-291x(89)92478-9. Biochem Biophys Res Commun. 1989. PMID: 2719685 - Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD. Schapira AH, et al. J Neurochem. 1990 Dec;55(6):2142-5. doi: 10.1111/j.1471-4159.1990.tb05809.x. J Neurochem. 1990. PMID: 2121905 - Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J. Ebadi M, et al. Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889. Biol Signals Recept. 2001. PMID: 11351130 Review. - Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies.
Singer TP, Ramsay RR, Ackrell BA. Singer TP, et al. Biochim Biophys Acta. 1995 May 24;1271(1):211-9. doi: 10.1016/0925-4439(95)00030-8. Biochim Biophys Acta. 1995. PMID: 7599211 Review.
Cited by
- DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress.
Mullett SJ, Di Maio R, Greenamyre JT, Hinkle DA. Mullett SJ, et al. J Mol Neurosci. 2013 Mar;49(3):507-11. doi: 10.1007/s12031-012-9904-4. Epub 2012 Oct 15. J Mol Neurosci. 2013. PMID: 23065353 Free PMC article. - Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo.
Chambers JW, Howard S, LoGrasso PV. Chambers JW, et al. J Biol Chem. 2013 Jan 11;288(2):1079-87. doi: 10.1074/jbc.M112.421354. Epub 2012 Nov 26. J Biol Chem. 2013. PMID: 23184940 Free PMC article. - A guide to neurotoxic animal models of Parkinson's disease.
Tieu K. Tieu K. Cold Spring Harb Perspect Med. 2011 Sep;1(1):a009316. doi: 10.1101/cshperspect.a009316. Cold Spring Harb Perspect Med. 2011. PMID: 22229125 Free PMC article. Review. - Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.
Lin MT, Cantuti-Castelvetri I, Zheng K, Jackson KE, Tan YB, Arzberger T, Lees AJ, Betensky RA, Beal MF, Simon DK. Lin MT, et al. Ann Neurol. 2012 Jun;71(6):850-4. doi: 10.1002/ana.23568. Ann Neurol. 2012. PMID: 22718549 Free PMC article. - The Protective Effect of Uridine in a Rotenone-Induced Model of Parkinson's Disease: The Role of the Mitochondrial ATP-Dependent Potassium Channel.
Mironova GD, Mosentsov AA, Mironov VV, Medvedeva VP, Khunderyakova NV, Pavlik LL, Mikheeva IB, Shigaeva MI, Agafonov AV, Khmil NV, Belosludtseva NV. Mironova GD, et al. Int J Mol Sci. 2024 Jul 6;25(13):7441. doi: 10.3390/ijms25137441. Int J Mol Sci. 2024. PMID: 39000550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical